- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 33
Comparing Dosage and Duration of Treatment
Presentation: Analgesics for Osteoarthritis—An Update
Keywords: comparative adverse effects | outcomes | strength of evidence | NSAIDs | dosage | CV risk | GI risk
Effects of Adding an H-2 Antagonist, Misoprostol, or a PPI on GI Adverse Effects Associated With NSAIDs (1 of 3)
Presentation: Analgesics for Osteoarthritis—An Update
Keywords: GI risk | H-2 antagonist | misoprostol | NSAIDs | PPI | strength of evidence | outcomes
Topical Analgesics (2 of 2)
Presentation: Analgesics for Osteoarthritis—An Update
Keywords: outcomes | strength of evidence | NSAIDs | topical analgesics
Evidence on Adverse Effects
Adverse Effects of Interest in the Comparative Effectiveness Review
Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | adverse effects
Comparative Adverse Effects of Biologic DMARDs (2 of 3)
Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: Rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic DMARD | mixed treatment comparison | certolizumab pegol | etanercept | rituximab | infliximab | etanercept | anakinra | infusion reaction | injection site reaction
Comparative Adverse Effects of Biologic DMARDs (3 of 3)
Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic DMARD | lymphoma | methotrexate
Summary of Benefits: DMARD Combinations Versus Monotherapies (2 of 2)
Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic DMARD | withdrawal | methotrexate | functional capacity | quality of life
Comparative Adverse Effects of Combining DMARDs
Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic DMARD | withdrawal | adverse events | tolerability | methotrexate | adverse effects
Summary of Benefits: DMARDs in the Treatment of Patients With Early Rheumatoid Arthritis (2 of 2)
Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic DMARD | withdrawal | adverse events | adverse effects | radiographic evidence | radiographic progression | early RA | aggressive RA | methotrexate | abatacept | adalimumab | etanercept | infliximab | remission | symptom response
Comparative Adverse Effects of DMARDs for Patients With Early Rheumatoid Arthritis
Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | methotrexate | oral DMARD | biologic DMARD | adverse effects | prednisone | sulfasalazine | methotrexate
Conclusions (3 of 4)
Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | methotrexate | prednisone | oral DMARD | biologic DMARD | withdrawal | adverse events | adverse effects
Your slide tray is being processed.